Literature DB >> 10641790

SPARC (osteonectin/BM-40).

K Motamed1.   

Abstract

SPARC (Secreted ProteinAcidic and Rich in Cysteine) is a prototype of a family of biologically active glycoproteins that bind to cells and to extracellular matrix (ECM) components. It is expressed spatially and temporally during embryogenesis, tissue remodeling and repair. SPARC is a modular protein (34 kDa) comprised of three structural domains, one or more of which are implicated in the regulation of cell adhesion, proliferation, matrix synthesis/turnover. Rapid proteolysis of SPARC by extracellular proteases accounts for its transient detection in the extracellular environment. The proposed roles of SPARC in the development of cataracts and the regulation of angiogenesis during wound healing and tumor growth account for the recent attention it has received from the biomedical community.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10641790     DOI: 10.1016/s1357-2725(99)00090-4

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  31 in total

1.  Induction of SC1 mRNA encoding a brain extracellular matrix glycoprotein related to SPARC following lesioning of the adult rat forebrain.

Authors:  D B Mendis; G O Ivy; I R Brown
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

2.  Generalized T2 test for genome association studies.

Authors:  Momiao Xiong; Jinying Zhao; Eric Boerwinkle
Journal:  Am J Hum Genet       Date:  2002-03-29       Impact factor: 11.025

3.  Toward a high-throughput approach to quantitative proteomic analysis: expression-dependent protein identification by mass spectrometry.

Authors:  T J Griffin; D K Han; S P Gygi; B Rist; H Lee; R Aebersold; K C Parker
Journal:  J Am Soc Mass Spectrom       Date:  2001-12       Impact factor: 3.109

4.  SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer.

Authors:  Hong Zhang; Emma Widegren; Da-Wei Wang; Xiao-Feng Sun
Journal:  Tumour Biol       Date:  2011-09-02

5.  DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling.

Authors:  Jung-Min Kim; Hong-In Shin; Sun-Shin Cha; Chang Sup Lee; Bok Sil Hong; Seyoung Lim; Hyun-Jun Jang; Jaeyoon Kim; Yong Ryoul Yang; Yun-Hee Kim; Sanguk Yun; Girdhari Rijal; Whaseon Lee-Kwon; Jeong Kon Seo; Yong Song Gho; Sung Ho Ryu; Eun-Mi Hur; Pann-Ghill Suh
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 6.  Anti-cancer role of SPARC, an inhibitor of adipogenesis.

Authors:  Ganji Purna Chandra Nagaraju; Dipali Sharma
Journal:  Cancer Treat Rev       Date:  2011-01-14       Impact factor: 12.111

7.  Osteogenic properties of late adherent subpopulations of human bone marrow stromal cells.

Authors:  Elisa Leonardi; Gabriela Ciapetti; Serena Rubina Baglìo; Valentina Devescovi; Nicola Baldini; Donatella Granchi
Journal:  Histochem Cell Biol       Date:  2009-08-27       Impact factor: 4.304

8.  Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.

Authors:  Izabela Podgorski; Bruce E Linebaugh; Jennifer E Koblinski; Deborah L Rudy; Mackenzie K Herroon; Mary B Olive; Bonnie F Sloane
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

9.  Enzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivo.

Authors:  Amy H Van Hove; Kathleen Burke; Erin Antonienko; Edward Brown; Danielle S W Benoit
Journal:  J Control Release       Date:  2015-09-11       Impact factor: 9.776

10.  Identification of genes differentially expressed in benign versus malignant thyroid tumors.

Authors:  Nijaguna B Prasad; Helina Somervell; Ralph P Tufano; Alan P B Dackiw; Michael R Marohn; Joseph A Califano; Yongchun Wang; William H Westra; Douglas P Clark; Christopher B Umbricht; Steven K Libutti; Martha A Zeiger
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.